Cargando…

Significance of 5-S-Cysteinyldopa as a Marker for Melanoma

Melanoma is one of the most lethal and malignant cancers and its incidence is increasing worldwide, and Japan is not an exception. Although there are numerous therapeutic options for melanoma, the prognosis is still poor once it has metastasized. The main concern after removal of a primary melanoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wakamatsu, Kazumasa, Fukushima, Satoshi, Minagawa, Akane, Omodaka, Toshikazu, Hida, Tokimasa, Hatta, Naohito, Takata, Minoru, Uhara, Hisashi, Okuyama, Ryuhei, Ihn, Hironobu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013534/ https://www.ncbi.nlm.nih.gov/pubmed/31936623 http://dx.doi.org/10.3390/ijms21020432

Ejemplares similares

Utility of Melanin Degradation Products in the Nail for Diagnosing Nail Apparatus Melanoma
por: MIYAKE, Tomomi, et al.
Publicado: (2021)

Determination of 5-S-cysteinyldopa in melanomas with a fluorimetric method.
por: Rorsman, H., et al.
Publicado: (1973)

Elucidation of Melanogenesis Cascade for Identifying Pathophysiology and Therapeutic Approach of Pigmentary Disorders and Melanoma
por: Hida, Tokimasa, et al.
Publicado: (2020)

Halo formations around senile hemangiomas in diffuse plane normolipemic xanthomatosis associated with monoclonal gammopathy
por: Hida, Tokimasa, et al.
Publicado: (2018)

Malignant melanoma of the male urethra with increased 5‐S‐cysteinyldopa: A case report
por: Aoki, Yusuke, et al.
Publicado: (2019)

3D Spheroid Configurations Are Possible Indictors for Evaluating the Pathophysiology of Melanoma Cell Lines
por: Ohguro, Hiroshi, et al.
Publicado: (2023)

Late Onset of Cardiac Metastasis of a Melanoma following Nivolumab Immunotherapy
por: Nakamura, Kenta, et al.
Publicado: (2022)

Late Onset of Acute Urticaria after Bee Stings
por: Asai, Yuko, et al.
Publicado: (2016)

Molecular Events in the Melanogenesis Cascade as Novel Melanoma-Targeted Small Molecules: Principle and Development
por: Wakamatsu, Kazumasa, et al.
Publicado: (2022)

Combination of serum 5-S-cysteinyldopa, melanoma inhibitory activity and IL-8 improves the diagnostic accuracy of malignant melanoma compared with individual markers
por: Katoh, Yuki, et al.
Publicado: (2022)

Efficacy and safety of nivolumab in Japanese patients with previously untreated advanced melanoma: A phase II study
por: Yamazaki, Naoya, et al.
Publicado: (2017)

Long‐term follow up of nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma
por: Yamazaki, Naoya, et al.
Publicado: (2019)

Blue nodule on the finger
por: Suwa, Manabu, et al.
Publicado: (2019)

Pink nodule accompanied with clustered yellow globules at the periphery
por: Mikoshiba, Yasutomo, et al.
Publicado: (2017)

Near-ultraviolet Light Dermoscopy for Identification of Pigmented Skin Tumours
por: MINAGAWA, Akane, et al.
Publicado: (2023)

Immunomodulation of Melanoma by Chemo-Thermo-Immunotherapy Using Conjugates of Melanogenesis Substrate NPrCAP and Magnetite Nanoparticles: A Review
por: Tamura, Yasuaki, et al.
Publicado: (2022)

IL‐13 modulates ∆Np63 levels causing altered expression of barrier‐ and inflammation‐related molecules in human keratinocytes: A possible explanation for chronicity of atopic dermatitis
por: Kubo, Terufumi, et al.
Publicado: (2021)

Five‐year survival with nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma
por: Uhara, Hisashi, et al.
Publicado: (2021)

Investigation of FOXM1 as a Potential New Target for Melanoma
por: Miyashita, Azusa, et al.
Publicado: (2015)

Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma
por: Yamazaki, Naoya, et al.
Publicado: (2017)

A Case of Mycobacterial Skin Disease Caused by Mycobacterium peregrinum, and a Review of Cutaneous Infection
por: Kamijo, Fuminao, et al.
Publicado: (2012)

Certolizumab pegol treatment for leg ulcers due to rheumatoid vasculitis
por: Meling, Maureen Tania, et al.
Publicado: (2021)

Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma
por: Fujisawa, Yasuhiro, et al.
Publicado: (2019)

Dermoscopy of Melanoma and Non-melanoma Skin Cancers
por: Kato, Junji, et al.
Publicado: (2019)

Clinical Significance of Serum Vascular Endothelial-Cadherin Levels in Inflammatory Skin Diseases
por: Kuriyama, Haruka, et al.
Publicado: (2014)

Alopecia areata as an immune-related adverse event associated with response to immune checkpoint inhibitors
por: Suzuki, Rika, et al.
Publicado: (2023)

Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level
por: Sakaizawa, K, et al.
Publicado: (2012)

Phase 1b study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced melanoma (KEYNOTE-041)
por: Yamazaki, Naoya, et al.
Publicado: (2017)

Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma
por: Yamazaki, N., et al.
Publicado: (2015)

Intratumoral expression levels of PD-L1, GZMA, and HLA-A along with oligoclonal T cell expansion associate with response to nivolumab in metastatic melanoma
por: Inoue, Hiroyuki, et al.
Publicado: (2016)

Adjuvant therapy with nivolumab versus ipilimumab after complete resection of stage III/IV melanoma: Japanese subgroup analysis from the phase 3 CheckMate 238 study
por: Yokota, Kenji, et al.
Publicado: (2019)

Changes in the Immune Cell Repertoire for the Treatment of Malignant Melanoma
por: Nakamura, Kenta, et al.
Publicado: (2022)

Geographical Flushing of the Children's Face: A New Clinical Entity?
por: Jinnin, Masatoshi, et al.
Publicado: (2013)

Phase II study of the immune-checkpoint inhibitor ipilimumab plus dacarbazine in Japanese patients with previously untreated, unresectable or metastatic melanoma
por: Yamazaki, N., et al.
Publicado: (2015)

Agouti protein, mahogunin, and attractin in pheomelanogenesis and melanoblast-like alteration of melanocytes: a cAMP-independent pathway
por: Hida, Tokimasa, et al.
Publicado: (2009)

BRAF Mutation Heterogeneity in Melanoma Lesions
por: SAKAIZAWA, Kaori, et al.
Publicado: (2020)

Safety and effectiveness of nivolumab in Japanese patients with malignant melanoma: Final analysis of a post‐marketing surveillance
por: Uhara, Hisashi, et al.
Publicado: (2022)

Final analysis of a phase II study of nivolumab in combination with ipilimumab for unresectable chemotherapy‐naive advanced melanoma
por: Namikawa, Kenjiro, et al.
Publicado: (2020)

Transcription factor LSF (TFCP2) inhibits melanoma growth
por: Goto, Yuji, et al.
Publicado: (2015)

Diagnostic Utility of a Revised Formula-based Melanoma Discrimination Index for Nail Streaks in Dermoscopic Practice
por: MINAGAWA, Akane, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_or5eedog93psm911h9bnpqa43r